CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
Authors
Robert Bollinger
Nele Brusselaers
+7Â more
Allan Buzibye
Barbara Castelnuovo
Ronald Kiguba
Frank Mulindwa
Martin Nabwana
Eva Laker Agnes Odongpiny
Jean-Marc Schwarz
Publication date
1 January 2023
Publisher
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Institutional Repository Universiteit Antwerpen
See this paper in CORE
Go to the repository landing page
Download from data provider
c:irua:200383
Last time updated on 23/11/2023